Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia

被引:12
|
作者
Dymova, Maya A. [1 ,2 ]
Cherednichenko, Andrey G. [3 ]
Alkhovik, Olga I. [3 ]
Khrapov, Eugeny A. [1 ]
Petrenko, Tatjana I. [3 ]
Filipenko, Maxim L. [1 ,2 ]
机构
[1] Russian Acad Sci SB RAS, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia
[2] Novosibirsk State Univ, Novosibirsk 630090, Russia
[3] Novosibirsk Res Inst TB, Minist Publ Hlth & Social Dev Russian Federat NRI, Novosibirsk, Russia
关键词
Mycobacterium tuberculosis; Multidrug resistance; Drug-resistance mutations; Genotyping; BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; IN-VITRO; STRAINS; MUTATIONS; RIFAMPIN; RPOB; INFECTIONS; RUSSIA; GENES;
D O I
10.1186/1471-2334-14-478
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis compromises effective control of tuberculosis (TB) in Siberia. Early identification of drug-resistant isolates is, therefore, crucial for effective treatment of this disease. The aim of this study was to conduct drug susceptibility testing and identify mutations in drug resistance genes in clinical isolates of M. tuberculosis from some TB patients presenting for treatment in Siberia. Methods: Thirty randomly selected clinical isolates of M. tuberculosis were obtained from the Novosibirsk Research Institute of Tuberculosis, Russia. Isolates were screened for drug resistance and characterized by variable number of tandem repeats (VNTR)-typing using 15 standard and four additional loci. Deligotyping on multiple large sequences was performed using 10 loci. Results: Twenty-nine of the isolates were assigned XDR status. Twenty-eight isolates belonged to the M. tuberculosis Beijing family, from which 11 isolates were considered the M11 type (39%), two the M2 type (7%), and one the M33 type (3%). Seventeen isolates (60.7%) from this family exhibited unique genetic patterns. The remaining two isolates belonged to the Latino-American Mediterranean family. Gene sequences (rpoB, katG, rrs, rpsL, tlyA, gidB, gyrA, gyrB) were analyzed to identify mutations that confer resistance to rifampicin, isoniazid, amikacin, kanamycin, capreomycin, and ofloxacin. The most common mutations among the XDR isolates were S531L in RpoB, S315T in KatG, various codon 94 mutations in gyrA, A90V in GyrA, K43R in RpsL, and 1401 A -> G in rrs; these confer resistance to rifampicin, isoniazid, ofloxacin, streptomycin and kanamycin/capreomycin, respectively. There was high congruence between the two typing methods (VNTR typing and deligotyping) and RD105, RD149, RD152, RD181, and RD207 regions of difference were absent from the 28 Beijing family isolates. Conclusions: Deligotyping can be used for rapid and reliable screening of M. tuberculosis isolates, followed by more in-depth genotyping. Identification of Beijing family isolates with extensive drug resistance confirms that such strains have epidemiological importance in Siberia. Rapid detection of mutations that lead to drug resistance should facilitate selection of effective drug therapies, and the development of early prevention strategies to combat this infection.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Update on extensively drug-resistant tuberculosis
    Elgin, Nancy
    [J]. AMERICAN JOURNAL OF NURSING, 2007, 107 (06) : 19 - 19
  • [42] Multidrug and extensively drug-resistant tuberculosis
    Maitre, T.
    Aubry, A.
    Jarlier, V.
    Robert, J.
    Veziris, N.
    Bernard, C.
    Sougakoff, W.
    Brossier, F.
    Cambau, E.
    Mougari, F.
    Raskine
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2017, 47 (01): : 3 - 10
  • [43] Extensively Drug-Resistant Tuberculosis, Pakistan
    Hasan, Rumina
    Jabeen, Kauser
    Ali, Asho
    Rafiq, Yasraba
    Laiq, Rabia
    Malik, Babar
    Tanveer, Mahnaz
    Groenheit, Ramona
    Ghebremichael, Solomon
    Hoffner, Sven
    Hasan, Zahra
    [J]. EMERGING INFECTIOUS DISEASES, 2010, 16 (09) : 1473 - 1475
  • [44] The threat of extensively drug-resistant tuberculosis
    Mohapatra, Prasanta Raghab
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (06) : 888 - 889
  • [45] Extensively Drug-Resistant Tuberculosis, China
    Tang, Shenjie
    Zhang, Qing
    Yu, Jinming
    Liu, Yidian
    Sha, Wei
    Sun, Hue
    Fan, Lin
    Gu, Jin
    Hao, Xiaohui
    Yao, Lan
    Xiao, Heping
    [J]. EMERGING INFECTIOUS DISEASES, 2011, 17 (03) : 558 - 560
  • [46] Spread of extensively drug-resistant tuberculosis
    Samper, Sofia
    Martin, Carlos
    [J]. EMERGING INFECTIOUS DISEASES, 2007, 13 (04) : 647 - 648
  • [47] Management of extensively drug-resistant tuberculosis
    Centis, Rosella
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (04): : 237 - 239
  • [48] Extensively Drug-Resistant Tuberculosis, Pakistan
    Hasan, Rumina
    Jabeen, Kauser
    Ali, Asho
    Rafiq, Yasraba
    Laiq, Rabia
    Malik, Babar
    Tanveer, Mahnaz
    Groenheit, Ramona
    Ghebremichael, Solomon
    Hoffner, Sven
    Hasan, Zahra
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (01) : S80 - S82
  • [49] Delamanid for Extensively Drug-Resistant Tuberculosis
    Gupta, Rajesh
    Geiter, Lawrence J.
    Wells, Charles D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03): : 291 - 292
  • [50] Linezolid for Extensively Drug-Resistant Tuberculosis
    Cattaneo, Dario
    Orlando, Giovanna
    Cordier, Laura
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03): : 291 - 291